A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

A new study led by researchers at Adelaide University and published in Science Advances has revealed why some cancers can grow and survive in the body, while others cannot. It turns out that intense ...

Historic redlining, a U.S. policy outlawed nearly 6 decades ago for segregating neighborhoods based on their racial makeup, still negatively impacts survival from breast cancer, according to results ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

In this study, researchers aimed to determine whether overall survival is superior with first-line CDK4/6i use compared to second-line use in HR-positive, HER-negative advanced breast cancer.

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

A woman in her 30s was diagnosed with colorectal cancer after six years of doctors dismissing symptoms, believing they were childbirth side effects.

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

Cycle for Survival is a high energy spin event that raises money to help treat rare cancers at Memorial Sloan Kettering. It ...

A gastroenterologist at the Mayo Clinic who treats patients with colorectal cancer shares the warning signs of the disease he'd look for in his own body.